Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02973399 |
Title | Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Esanex Inc. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Weill Cornell Medical College | New York | New York | 10065 | United States | Details | |
Wexner Medical Center, Ohio State University | Columbus | Ohio | 43210 | United States | Details |